prof. Sofie Verbeke

Journal Article

Heelkundige uitkomst na lymfeklierdissectie bij lokaal gevorderd renaal cel carcinoom: een retrospectieve analyse

Dries Vandendriessche, Victor Declerck, Simon Pauwelijn, Camille Berquin (UGent) , Pieter De Visschere (UGent) , Sofie Verbeke (UGent) , Sylvie Rottey (UGent) , Karel Decaestecker (UGent) , Nicolaas Lumen (UGent) and Charles Van Praet (UGent)

(2026) Tijdschrift voor Geneeskunde.

Add to list

Journal Article
A1
open access

PSMA PET/CT-guided pelvic lymph node dissection in patients with unfavorable intermediate- or high-risk prostate cancer

Eva Donck (UGent) , Sofie Verbeke (UGent) , Pieter De Visschere (UGent) , Valerie Fonteyne (UGent) , Charles Van Praet (UGent) , Kathia De Man (UGent) and Nicolaas Lumen (UGent)

(2025) CANADIAN JOURNAL OF UROLOGY.

Add to list

Journal Article
A1
open access

Genomic determinants associated with modes of progression and patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer

Philip Sutera, Yang Song, Amol C. Shetty, Keara English, Kim Van der Eecken, Ozan Cem Guler, Jarey Wang, Yufeng Cao, Soha Bazyar, Sofie Verbeke (UGent) , et al.

(2025) EUROPEAN UROLOGY ONCOLOGY. 8(1). p.111-118

Add to list

Journal Article
A1
open access

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints

Flor Verghote (UGent) , Elke Rammant (UGent) , Piet Dirix, Charles Van Praet (UGent) , Charlien Berghen, Sara Junius, Nick Liefhooghe, Leen Noé, Piet Ost (UGent) , Karel Decaestecker (UGent) , et al.

(2025) EUROPEAN UROLOGY FOCUS.

Add to list

Journal Article
A1
open access

Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer

Daan De Maeseneer (UGent) , Pieter De Visschere (UGent) , Mats Van den broecke, Felix Delbare, Geert Villeirs (UGent) , Sofie Verbeke (UGent) , Valerie Fonteyne (UGent) , Charles Van Praet (UGent) , Karel Decaestecker (UGent) , Alexander Decruyenaere (UGent) , et al.

(2024) BMC MEDICAL IMAGING. 24(1).

Add to list

Rare type of Bellini duct carcinoma in a patient with Cacchi–Ricci disease : a case report and mini-review

Antonio Franco, Thomas Tailly (UGent) , Camille Berquin (UGent) , Daan De Maeseneer (UGent) , Alexander Decruyenaere (UGent) , Sofie Verbeke (UGent) , Pieter De Visschere (UGent) , Kathia De Man (UGent) , Laurens Hermie (UGent) , Ben Vanneste (UGent) , et al.

(2024) CLINICAL GENITOURINARY CANCER. 22(6).

Add to list

Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial

Valerie Fonteyne (UGent) , C Berghen, Charles Van Praet (UGent) , Barbara Vanderstraeten (UGent) , Sofie Verbeke (UGent) , Geert Villeirs (UGent) , Roos Colman (UGent) , Ben Vanneste (UGent) , Piet Ost (UGent) , G De Meerleer, et al.

(2024) RADIOTHERAPY AND ONCOLOGY. 193.

Add to list

PI-RADS 5 in prostate magnetic resonance imaging : how important is intraprostatic invasive behavior?

Ottavia Battaglia, Pieter De Visschere (UGent) , Sifrid Hendrickx (UGent) , Valerie Fonteyne (UGent) , Sofie Verbeke (UGent) , Charles Van Praet (UGent) and Geert Villeirs (UGent)

(2024) European Congress of Radiology 2024 (ECR 2024), Abstracts.

Add to list

Is it safe to change from a standard anterior approach to a Retzius-sparing approach in robot-assisted radical prostatectomy?

Edward Lambert (UGent) , Charlotte Allaeys, Camille Berquin (UGent) , Sofie Verbeke (UGent) , Pieter De Visschere (UGent) , Charles Van Praet (UGent) and Nicolaas Lumen (UGent)

(2023) EUROPEAN UROLOGY. In European Urology 83(Supplement 1). p.S1597-S1598

Add to list

Journal Article
A1
open access

Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer

Marija Pizurica (UGent) , Maarten Larmuseau (UGent) , Kim Van der Eecken, Louise de Schaetzen van Brienen (UGent) , Francisco Carrillo-Perez, Simon Isphording (UGent) , Nicolaas Lumen (UGent) , Jo Van Dorpe (UGent) , Piet Ost (UGent) , Sofie Verbeke (UGent) , et al.

(2023) CANCER RESEARCH. 83(17). p.2970-2984

Academic Bibliography

prof. Sofie Verbeke

Heelkundige uitkomst na lymfeklierdissectie bij lokaal gevorderd renaal cel carcinoom: een retrospectieve analyse

PSMA PET/CT-guided pelvic lymph node dissection in patients with unfavorable intermediate- or high-risk prostate cancer

Genomic determinants associated with modes of progression and patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints

Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer

Rare type of Bellini duct carcinoma in a patient with Cacchi–Ricci disease : a case report and mini-review

Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial

PI-RADS 5 in prostate magnetic resonance imaging : how important is intraprostatic invasive behavior?

Is it safe to change from a standard anterior approach to a Retzius-sparing approach in robot-assisted radical prostatectomy?

Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer

Contents

Support

Contact